CEL-SCI Corporation

Akonni Biosystems, based in Frederick, MD, is a leading molecular diagnostics company specializing in the development and manufacturing of integrated molecular diagnostic instruments and consumables. Their innovative products, such as the TruTip nucleic acid purification kits and TruDiagnosis IVD systems, offer flexible solutions for a wide range of laboratory needs. With a strong focus on technology and research, Akonni holds over 40 issued patents covering various aspects of their core technologies, including specimen homogenization, nucleic acid purification, and 3D gel drop microarrays. Recognized for their groundbreaking work, Akonni Biosystems continues to revolutionize the molecular testing market with game-changing solutions for rapid and accurate disease detection.Generated from the website

MedStar Research Institute is the research center of MedStar Health, a $2.7 billion nonprofit health care organization and a community-based network of seven hospitals and other health care services in the Baltimore-Washington region. The purpose of the institute is to conduct and support medical research that results in better treatments and prevention strategies for the major diseases affecting the communities it serves. The organization employs more than 23,000 staff members and 4,600 affiliated physicians. It serves more than 145,000 patients each day and more than 1 million patients each year. In 2005, MedStar Health co-sponsored the Bristol-Myers Squibb Tour of Hope fundraising bike ride. MedStar Research Institute is located in Hyattsville, Md.

Orgenesis Inc, based in Germantown, MD, is a pioneering company dedicated to unlocking the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. Their innovative POCare Platform offers a pathway to lower costs and standardized CGTs, aiming to bring advanced therapies to patients globally. With a focus on personalized CGTs, Orgenesis is committed to addressing the world's most challenging diseases. Through collaborations with biotech industry leaders, research institutes, and hospitals, they are revolutionizing drug development and scale-up, making advanced therapies more accessible to those in need.Generated from the website